103 related articles for article (PubMed ID: 17998283)
21. High expression of p63 is correlated to poor prognosis in squamous cell carcinoma of the tongue.
Loljung L; Coates PJ; Nekulova M; Laurell G; Wahlgren M; Wilms T; Widlöf M; Hansel A; Nylander K
J Oral Pathol Med; 2014 Jan; 43(1):14-9. PubMed ID: 23607508
[TBL] [Abstract][Full Text] [Related]
22. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma.
Pokorna Z; Hrabal V; Tichy V; Vojtesek B; Coates PJ
Front Oncol; 2022; 12():924354. PubMed ID: 35912167
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of p63 protein in human esophageal squamous cell carcinomas.
Hu H; Xia SH; Li AD; Xu X; Cai Y; Han YL; Wei F; Chen BS; Huang XP; Han YS; Zhang JW; Zhang X; Wu M; Wang MR
Int J Cancer; 2002 Dec; 102(6):580-3. PubMed ID: 12447998
[TBL] [Abstract][Full Text] [Related]
24. The foggy world(s) of p63 isoform regulation in normal cells and cancer.
Pokorná Z; Vysloužil J; Hrabal V; Vojtěšek B; Coates PJ
J Pathol; 2021 Jul; 254(4):454-473. PubMed ID: 33638205
[TBL] [Abstract][Full Text] [Related]
25. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
[TBL] [Abstract][Full Text] [Related]
26. The downregulation of ΔNp63 in p53-deficient mouse epidermal tumors favors metastatic behavior.
Bornachea O; López-Calderón FF; Dueñas M; Segrelles C; Lorz C; Suárez-Cabrera C; Marañón M; Paradela-Dobarro B; Santos M; Paramio JM
Oncotarget; 2015 Sep; 6(27):24230-45. PubMed ID: 26203771
[TBL] [Abstract][Full Text] [Related]
27. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
[TBL] [Abstract][Full Text] [Related]
28. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
[TBL] [Abstract][Full Text] [Related]
29. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach.
Birkaya B; Ortt K; Sinha S
BMC Mol Biol; 2007 May; 8():43. PubMed ID: 17521434
[TBL] [Abstract][Full Text] [Related]
30. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation.
Chiang CT; Chu WK; Chow SE; Chen JK
J Cell Physiol; 2009 Apr; 219(1):117-22. PubMed ID: 19089994
[TBL] [Abstract][Full Text] [Related]
32. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress.
Yao JY; Chen JK
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):310-5. PubMed ID: 21075072
[TBL] [Abstract][Full Text] [Related]
33. [Expression of DeltaNp63 protein in nasopharyngeal carcinoma and its significance].
Liao ZL; Deng ZL; Zhang B; Xie KS
Ai Zheng; 2004 Mar; 23(3):288-91. PubMed ID: 15025959
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activity of TAp63 promoter is regulated by c-jun.
Yao JY; Pao CC; Chen JK
J Cell Physiol; 2010 Nov; 225(3):898-904. PubMed ID: 20607803
[TBL] [Abstract][Full Text] [Related]
35. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Int J Exp Pathol; 2004 Apr; 85(2):97-104. PubMed ID: 15154915
[TBL] [Abstract][Full Text] [Related]
37. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
[TBL] [Abstract][Full Text] [Related]
38. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.
Levesque MA; Katsaros D; Yu H; Zola P; Sismondi P; Giardina G; Diamandis EP
Cancer; 1995 Mar; 75(6):1327-38. PubMed ID: 7882283
[TBL] [Abstract][Full Text] [Related]
39. [The two faces of p63, Janus of the p53 gene family].
Caron de Fromentel C; Aberdam E; Aberdam D
Med Sci (Paris); 2012 Apr; 28(4):381-7. PubMed ID: 22549865
[TBL] [Abstract][Full Text] [Related]
40. Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells.
Park GB; Jeong JY; Kim D
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31336860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
